A Hybrid AI and Rule-Based Decision Support System for Disease Diagnosis and Management Using Labs

Muhammad Hammad Maqsood, Mubashir Sajid, Khubaib Ahmed, Muhammad Usamah Shahid, Muddassar Farooq · 2026

Read A Hybrid AI and Rule-Based Decision Support System for Disease Diagnosis and Management Using Labs by Muhammad Hammad Maqsood, Mubashir Sajid, Khubaib Ahmed, Muhammad Usamah Shahid, Muddassar Farooq (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2603-14876.txt.

Introduction

Maqsood and co-authors fuse AI prediction with a rule base for diagnosis support from lab results. Lab values carry quantifiable clues that can point to likely diseases. Their system pairs data-driven predictors with a clinically checked rule base. Data from 593,055 patients at 547 US primary care centers ground the build. Rules cover 59 conditions and can assign ICD-10 codes directly. A likely-diagnosis model spans 37 codes in 11 lab-based groups. Suggested follow-up tests help doctors confirm each lead.

Catalog record

CREATORMuhammad Hammad Maqsood, Mubashir Sajid, Khubaib Ahmed, Muhammad Usamah Shahid, Muddassar Farooq
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE20798
LICENSEhttp://creativecommons.org/licenses/by/4.0/
RIGHTSCC BY
SOURCEarXiv

Source: https://arxiv.org/abs/2603.14876

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

A Hybrid AI and Rule-Based Decision Support System for Disease Diagnosis and Management Using Labs Muhammad Hammad Maqsood, Mubashir Sajid, Khubaib Ahmed, Muhammad Usamah Shahid, Muddassar Farooq Abstract This research paper outlines the development and implementation of a novel Clinical Decision Support System (CDSS) that integrates AI predictive modeling with medical knowledge bases. It utilizes the quantifiable information elements in lab results for inferring likely diagnoses a patient might have. Subsequently, suggesting investigations to confirm the likely diagnoses – an assistive tool for physicians. The system fuses knowledge contained in a rule-base expert system with inferences of data driven predictors based on the features in labs. The data for 593,055 patients was collected from 547 primary care centers across the US to model our decision support system and derive Real-Word Evidence (RWE) to make it relevant for a large demographic of patients. Our Rule-Base comprises clinically validated rules, modeling 59 health conditions that can directly confirm one or more of diseases and assign ICD-10 codes to them. The Likely Diagnosis system uses multi-class classification, covering 37 ICD-10 codes, which are grouped together into 11 categories based on the labs that physicians prescribe to confirm the diagnosis. This research offers a novel system that assists a physician by utilizing medical profile of a patient and routine lab investigations to predict a group of likely diseases and then confirm them, coupled with providing explanations for inferences, thereby assisting physicians to reduce misdiagnosis of patients in clinical decision-making. 1 Introduction Clinical Decision Support Systems (CDSS) are vital tools in modern healthcare, designed to enhance medical decisions by leveraging knowledge and patients’ data to provide insights. These systems help physicians use RWE derived from Real World EMR Data. These systems integrate data from a variety of sources to recommend actionable interventions, improving patient outcomes and streamlining healthcare processes. They assist healthcare providers by offering decision-support tools that are directly integrated into clinical workflows of EMR systems. CDSS have been shown to improve valued based outcome for patients by reducing the cost of healthcare services. CDSS tools have been proposed that either utilize predictive modeling or draw inference using the rules in a medical rule base system [ 14 ] . Despite advances in technology, many clinical decision support systems (CDSS) remain restricted, primarily utilizing either rule-based algorithms or classical artificial intelligence (AI) techniques without fully integrating both approaches to harness their combined potential [ 4 ] . Knowledge driven rule-based system have historically enjoyed higher acceptability among physicians as the rules can be clinically validated by providers. They incorporate domain knowledge directly into the system and assist in the decision making of a physician. In these systems, modelling knowledge representation and upgrading continuously is a significant challenge; as a result, gaps in care holes pop in these systems [ 10 ] with advancements in medical knowledge and associated technologies. Machine learning (ML) and big data analytics have enhanced the sophistication of CDSS systems. Modern CDSS systems leverage ML models to offer predictive analytics and patient centered recommendations [ 2 ] [ 4 ] . These ML algorithms are able to achieve higher accuracy for a number of chronic diseases. Clinicians are, however, reluctant to trust these systems because of their black box type nature of making inferences. The trust and acceptability of Predictive ML models in healthcare is increasing [ 1 ] , especially as assistive tools, for the models that also explain their inference method. In this paper, we make efforts to add explainability layer on all ML tools. The major contributions of this research include: (1) the fusion of Knowledge Base with ML Models to design a Hybrid CDSS; (2) Utilization of quantifiable information in Laboratory Data for designing Likely diagnoses models for patients; and (3) Explanation of inferences to a physician using SHAP values to take informed decisions with the assistance of AI models. 2 The Proposed CDSS 2.1 System Overview This paper introduces a CDSS that integrates Machine Learning (ML) with a rule-based framework to provide a robust support mechanism for diagnosing a wide range of diseases with a focus on interpretability of the system shown in Figure 2 . It has the following components. Diagnosis Confirming Module This component assigns International Classification of Diseases (ICD-10) codes to patients based on a disease specific rule base, made using clinical guidelines of relevant associations or institutes, by facotring in demographics and and laboratory results. Likely Diagnosis Assistive Module By analyzing laboratory results, which offer a quantifiable snapshot of a patient’s health profile, this component predicts potential diagnoses and helps physicians in focusing their diagnostic efforts. D. Jing and M.Jing have demonstrated the potential for predicting diagnosis using laboratory results with the help of multi-class classification, achieving an F1 score of 0.76 [ 13 ] . Using multi-class classification on grouped diseases allows physicians to maintain focus during the process of diagnosis confirmation among a group of likely diagnoses options. For diseases that are deemed highly likely, the system also recommends further investigations to confirm these diagnoses, ensuring that the new information aids in patient centered decision-making by complying with the clinical guidelines. Figure 1 : Proposed Clinical Decision Support System Figure 2 : CDSS Workflow CDSS Output 1. Rule-Based Diagnosis Confirmation. The CDSS confirms diagnosis based on a predefined rule set that is applied to lab results and outputs ICD-10 codes. 2. Multiclass Probabilities (Likely Diagnosis). The system utilizes an XGBoost multi-class classifier to compute the probability of various potential diagnoses based on lab data and presents a ranked list of likely diagnoses to clinicians. 3. Prediction Explanation via SHAP Values. By quantifying the impact of each feature on the inference, SHAP values provide clinicians with explainable insights into rationale behind diagnostic inferences [ 16 ] and helps develop trust, essential for mainstream adoption of the ML based CDSS systems [ 8 ] 4. Recommendation for Follow-Up Labs. When a likely diagnosis is identified, the system suggests follow-up investigations that could confirm the diagnosis by reducing misdiagnosis rate. 3 Data Overview The dataset utilized for developing and validating the proposed Clinical Decision Support System (CDSS) uses demographic (age and gender) of patients, and laboratory results that are extracted from anonymized and de-identified CureMD EHR data, from 593,055 electronic medical records, making it a larger dataset from studies reported earlier in the literature ranging in sample size of 50,000 to 100,000 EMR records records [ 7 ] . These data sources are curated to maintain high standards of privacy and confidentiality, adhering to HIPAA guidelines. For instance, a systematic review of hospital length of stay prediction tools found median sample sizes of around 53,211 records [ 7 ] . 1. Geographical and Demographic Distribution. The data encompasses a wide distribution across different states, medical practices and demographics (age and gender) (seen in Appendix 5 6 ). The distribution of race is similar to the actual distribution of races [ 9 ] in the United States of America. This diversity mirrors the actual real world data, ensuring the system’s applicability across various healthcare settings and trustworthiness of RWE derived. 2. Disease Distribution. The dataset includes a varied distribution of diseases as seen in Table 1 , allowing the system to handle multiple diagnostic

Read the complete text